Brands
Commercial brands built on GMI and eExo-GMI, and the regulatory registrations behind each one.
Reishimmune®
GMI as a food ingredient — registered as a U.S. FDA New Dietary Ingredient and a Taiwan TFDA food raw material.
Regulatory basis: FDA New Dietary Ingredient NDI 1133、TFDA 食品原料 1111300075
Lumiderma®
GMI as a cosmetic ingredient — the protein itself, registered under PCPC INCI (US), COSING (EU), TFDA (Taiwan) and JCIA (Japan).
Regulatory basis: PCPC INCI 35581、COSING 99091、TFDA、JCIA 567713
eExo-GMI®
GMI encapsulated in yeast (Pichia) extracellular vesicles — a distinct cosmetic-line derivative of GMI, registered in the US, Taiwan and Japan.
Regulatory basis: PCPC INCI 39460、TFDA、JCIA 569028
New RS Protein®
GMI for animal and pet health applications.
MBM-106 (MM767593)
GMI as an investigational new drug substance. Trademarked by the parent company as MM767593 (derived from NCI/NIH substance number NSC 767593), licensed to the subsidiary and tracked under R&D pipeline code MBM-106. U.S. FDA Type II Drug Master File on file.
Regulatory basis: FDA Drug Master File (Type II) DMF 042597